fbpx
Donate Toggle Menu

Highlights from ASCO 2023

Below are some highlights from research presented at the 2023 meeting of the American Society of Clinical Oncology, which took place in Chicago, Illinois from June 2-6. Cabozantinib plus nivolumab is a promising treatment for…

Spotlight: Dr. Julia Stevens, Clinical Advisory Board

Dr. Julia Stevens, PharmD, BCOP, is a Clinical Pharmacy Specialist in Ambulatory Oncology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. She specializes in kidney cancer, prostate cancer, and melanoma. Her primary clinical responsibilities…

Spotlight: Dr. Emily Wang, Clinical Advisory Board

Dr. Emily Wang, PharmD, BCOP, is a Clinical Pharmacy Specialist – Genitourinary Medical Oncology at MD Anderson Cancer Center in Houston, Texas. What motivated you to get involved with the KCA? I had heard about…

Advocate Peggy Zuckerman on the cover of Cancer Today magazine

Peggy Zuckerman, a long-time kidney cancer patient, advocate, and member of the KCA’s Patient & Caregiver Advisory Council, was the featured cover story for Cancer Today magazine’s Summer 2023 issue. She was diagnosed with kidney…

Kidney cancer highlights from AUA 2023

Below are some of the research highlights from the 2023 American Urological Association Annual Meeting held on April 28 – May 1 in Chicago, Illinois.  Successful imaging of very small renal lesions New data from the phase…

AUA 2023 Highlight: Where does cytoreductive nephrectomy fit?

In a changing kidney cancer treatment landscape where immunotherapies and combination therapies have become more common as first-line treatments for patients, a number of presentations at the 2023 American Urological Association Annual Meeting held in…

1 5 6 7 8 9 31